case_images: PMC11699860_01
case_images: Chest CT changes during the course of pneumonia. (a) Large areas of consolidation (white arrow) in the middle-lower right lobe and pleural effusion during the first hospitalization when the patient was infected with Mycoplasma pneumoniae. (b) On the second admission, the consolidation (white arrow) in the right middle-lower lobe was significantly absorbed and decreased, and the pleural effusion disappeared. (c) After 2 weeks of nonspecific antifungal treatment, the consolidation (white arrow) in the right lobe progressed, accompanied by obstructive inflammation and lymphangitis. Pleural effusion also appeared. (d) Video bronchoscopy image showing a black fungating mass in the right principal bronchus (white arrow). (e) No further progression in the right lobe (white arrow) after 26 days of anti-mucor therapy. CT: computed tomography.
case_images: jmc-16-023-g001.jpg
case_images: PMC11699860_01_jmc-16-023-g001.jpg
case_images: F1
case_images: Chest computed tomography (CT) showed progressed areas of consolidation in the middle-lower lobe of the right lung (Fig. 1a). Reexamination of bone marrow smears showed 72% blasts, and chest CT still indicated pneumonia but less than before (Fig. 1b). Chest CT indicated the progression of pneumonia (Fig. 1c). Video-bronchoscopy showed that an endobronchial fungating mass leading to luminal obstruction in the right principal bronchus (Fig. 1d). Twenty-six days later, the patient's clinical symptoms and performance state were significantly improved, and chest CT showed no further progression (Fig. 1e).
case_images: The clinical and treatment course of the patient. The first day of chemotherapy is considered as day 1 (d1). ANC: absolute neutrophil count; PCT: procalcitonin; AZA: azacytidine; Pcz: posaconazole; ABCD: amphotericin B cholesteryl sulfate complex for injection.
case_images: jmc-16-023-g002.jpg
case_images: PMC11699860_01_jmc-16-023-g002.jpg
case_images: F2
case_images: The clinical course and timeline of the treatment course were summarized in Figure 2.